
Marker Therapeutics MRKR
€ 0.76
-1.19%
Land |
|
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
15.3 M |
Marktkapitalisierung |
$ 12.7 M |
EBITDA (LTM) |
$ -12.9 M |
P/E (LTM) |
-1.063291 |
P/S (LTM) |
3.626123 |
EPS (LTM) |
-0.79 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Foghorn Therapeutics
FHTX
|
$ 1.8 | -1.91 % | $ 113 M | Nasdaq Global Market | ||
|
Ocugen
OCGN
|
$ 0.73 | -2.88 % | $ 228 M | Nasdaq Capital Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.44 | 15.71 % | $ 42.2 M | Nasdaq Global Select Market | ||
|
Minerva Neurosciences
NERV
|
$ 2.18 | 0.93 % | $ 18.5 M | Nasdaq Global Market | ||
|
Kamada Ltd.
KMDA
|
$ 8.07 | -1.04 % | $ 465 M | Nasdaq Global Select Market | ||
|
Neurocrine Biosciences
NBIX
|
$ 162.75 | -1.91 % | $ 16.2 B | Nasdaq Global Select Market,SPB | ||
|
Nanobiotix S.A.
NBTX
|
$ 26.8 | -2.37 % | $ 1.28 T | Nasdaq Global Select Market | ||
|
Mereo BioPharma Group plc
MREO
|
$ 0.29 | 5.5 % | $ 231 M | Nasdaq Global Select Market | ||
|
Maravai LifeSciences Holdings
MRVI
|
$ 7.38 | 0.27 % | $ 1.07 B | Nasdaq Global Select Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.73 | -2.81 % | $ 628 M | Nasdaq Global Select Market | ||
|
Moleculin Biotech
MBRX
|
$ 6.86 | 0.44 % | $ 8.13 M | Nasdaq Global Select Market | ||
|
Arcus Biosciences
RCUS
|
$ 15.76 | -3.84 % | $ 1.69 B | NYSE,SPB | ||
|
Nurix Therapeutics
NRIX
|
$ 14.11 | -0.95 % | $ 1.22 B | Nasdaq Global Select Market,SPB | ||
|
Nkarta
NKTX
|
$ 1.2 | -4.4 % | $ 88.8 M | Nasdaq Global Select Market | ||
|
MacroGenics
MGNX
|
$ 1.98 | -3.66 % | $ 125 M | Nasdaq Global Select Market | ||
|
Protagonist Therapeutics
PTGX
|
$ 127.33 | 1.65 % | $ 8.09 B | Nasdaq Global Select Market | ||
|
Novo Nordisk A/S
NVO
|
$ 39.46 | -3.05 % | $ 175 B | NYSE | ||
|
Replimune Group
REPL
|
$ 19.81 | 0.61 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
NextCure
NXTC
|
$ 6.87 | 2.54 % | $ 36.5 M | Nasdaq Global Select Market | ||
|
Rocket Pharmaceuticals
RCKT
|
$ 2.13 | 1.18 % | $ 237 M | Nasdaq Global Select Market | ||
|
PMV Pharmaceuticals
PMVP
|
$ 1.23 | 0.41 % | $ 64.6 M | Nasdaq Global Select Market | ||
|
Olema Pharmaceuticals
OLMA
|
$ 7.17 | -0.76 % | $ 624 M | Nasdaq Global Select Market | ||
|
Kymera Therapeutics
KYMR
|
$ 121.2 | -0.27 % | $ 10.2 B | Nasdaq Global Market | ||
|
Oragenics
OGEN
|
$ 0.19 | -7.43 % | $ 410 K | NYSE American | ||
|
Ovid Therapeutics
OVID
|
$ 2.26 | 1.58 % | $ 294 M | Nasdaq Global Select Market | ||
|
Passage Bio
PASG
|
$ 4.18 | -0.95 % | $ 13.4 M | Nasdaq Global Select Market | ||
|
Vaxcyte
PCVX
|
$ 58.53 | -1.47 % | $ 7.97 B | Nasdaq Global Select Market | ||
|
Relay Therapeutics
RLAY
|
$ 16.52 | 0.33 % | $ 2.83 B | Nasdaq Global Market | ||
|
Precigen
PGEN
|
$ 4.26 | -0.7 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Avidity Biosciences
RNA
|
$ 6.65 | 2.62 % | $ 916 M | Nasdaq Global Select Market | ||
|
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.72 | 0.56 % | $ 4.31 M | Nasdaq Capital Market | ||
|
Praxis Precision Medicines
PRAX
|
$ 306.58 | 0.5 % | $ 6.9 B | Nasdaq Global Select Market,SPB | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.31 | -0.3 % | $ 255 M | Nasdaq Global Select Market | ||
|
ProQR Therapeutics N.V.
PRQR
|
$ 1.09 | -5.22 % | $ 115 M | Nasdaq Global Market | ||
|
Ocular Therapeutix
OCUL
|
$ 6.04 | 0.25 % | $ 1.13 B | Nasdaq Global Select Market | ||
|
Sana Biotechnology
SANA
|
$ 1.86 | -1.33 % | $ 471 M | Nasdaq Global Select Market | ||
|
Outlook Therapeutics
OTLK
|
$ 0.4 | 11.81 % | $ 13.9 M | Nasdaq Global Select Market | ||
|
United Therapeutics Corporation
UTHR
|
$ 577.46 | -1.14 % | $ 25.6 B | Nasdaq Global Select Market,SPB | ||
|
uniQure N.V.
QURE
|
$ 20.3 | -2.33 % | $ 1.17 B | Nasdaq Global Select Market | ||
|
Ultragenyx Pharmaceutical
RARE
|
$ 17.73 | 6.17 % | $ 1.75 B | Nasdaq Global Select Market,SPB | ||
|
Rafael Holdings
RFL
|
$ 0.95 | 3.48 % | $ 48.8 M | NYSE | ||
|
REGENXBIO
RGNX
|
$ 7.25 | 0.14 % | $ 374 M | Nasdaq Global Select Market,SPB | ||
|
Rigel Pharmaceuticals
RIGL
|
$ 42.57 | -0.82 % | $ 766 M | Nasdaq Global Select Market | ||
|
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | ||
|
Генетико
GECO
|
- | - | - | MOEX | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
Tenax Therapeutics
TENX
|
$ 1.44 | 1.41 % | $ 56.5 M | Nasdaq Global Select Market | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |